GABA Receptor Modulating Compounds for CNS Disorders
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for CNS-related disorders lack effective modulators of brain excitability, particularly for conditions like depression and anxiety, where GABA receptor modulation is crucial but not adequately addressed by existing compounds.
Innovation Solution
Development of novel compounds, represented by specific chemical formulas, that act as GABA modulators, targeting the GABAA receptor to modulate central nervous system excitability, thereby treating CNS-related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing compounds are used for treating CNS-related disorders, then current treatment protocols are maintained, but effective modulation of brain excitability through GABA receptors is not achieved
Solution Approach 1:
The patent applies parameter changes by systematically varying chemical structures of compounds to optimize their interaction with GABA receptors. Multiple compounds with different molecular configurations (Formula I, II, III, IV, V, VI, VII, VIII, IX, X) are designed to modulate receptor activity, transforming the chemical parameters to achieve desired therapeutic effects for CNS disorders.
Solution Approach 2:
The patent implements local quality by designing compounds with specific functional groups and molecular regions that target particular sites on the GABA receptor. Each compound contains strategically positioned substituents and structural elements that interact with specific receptor domains, enabling selective modulation of receptor activity to treat different CNS conditions.
2Reliability
If new GABA modulating compounds are developed, then effective treatment for CNS disorders is achieved, but complexity of compound structure increases
Solution Approach 1:
The patent applies segmentation by dividing the complex molecular structures into distinct functional modules and core frameworks. Each compound class (Formulas I-X) represents a segmented approach where specific structural elements can be independently optimized, synthesized, and combined to achieve desired GABA modulatory effects while managing overall molecular complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds effectively treat CNS-related disorders by modulating GABA receptor activity, providing therapeutic benefits for conditions such as depression and anxiety by influencing brain excitability.
Implementation Method 1
GABA interacts with its recognition site on the GRC to facilitate the flow of chloride ions down an electrochemical gradient of the GRC into the cell
Implementation Method 2
These compounds effectively treat CNS-related disorders by modulating GABA receptor activity, providing therapeutic benefits for conditions such as depression and anxiety by influencing brain excitability
Data Source
AI summary
Provided herein in part is a compound of Formula (I): or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of Formula I, and methods of using the compounds, e.g, in the treatment of CNS-related disorders.